Expression of E-cadherin and &beta;-catenin in gastric carcinoma and its correlation with the clinicopathological features and patient survival

doi:10.3748/wjg.v8.i6.987

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 8, Issue 6

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3966)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-3) series.

Item

Count

PDF

452

HTML

3110

Figures (1-2)

209

Tables (1-3)

195

Sum=3966

Dec 15, 2002 (publication date) through Oct 2, 2024

Times Cited of This Article

Times Cited (81)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Gastric Cancer

World J Gastroenterol. Dec 15, 2002; 8(6): 987-993
Published online Dec 15, 2002. doi: 10.3748/wjg.v8.i6.987

Full Size Figure Download Figure

Figure 2 Kaplan-Meier survival curves showing a statistically significant survival advantage found in all tumors with nor-mal membranous expression of β-catenin (B) compared with those with loss of membranous expression (P < 0. 0005). Abnormol E-cadherin (A) staining pattern showed a trend to-ward worse survival, but not statistically significant (P = 0.058).

Citation: Zhou YN, Xu CP, Han B, Li M, Qiao L, Fang DC, Yang JM. Expression of E-cadherin and β-catenin in gastric carcinoma and its correlation with the clinicopathological features and patient survival. World J Gastroenterol 2002; 8(6): 987-993
URL: https://www.wjgnet.com/1007-9327/full/v8/i6/987.htm
DOI: https://dx.doi.org/10.3748/wjg.v8.i6.987